Announcements Trials

Browse Landscape

Phase

Phase 2 45 Phase 1 20 Phase 3 13 Phase 1/2 11 Phase NA 2 Phase EARLY_PHASE1 2 Phase 4 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Dexamethasone 12 Bevacizumab 9 Saline Solution 8 Bupivacaine 8 Tobacco Use Cessation Devices 7 Specimen Handling 7 Nivolumab 7 Magnetic Resonance Spectroscopy 7 Rituximab 6 Prednisone 6 Letrozole 6 Lenalidomide 6 Fluorouracil 6 Cisplatin 6 Carboplatin 6 pembrolizumab 5 Sodium Chloride 5 Ropivacaine 5 Human Papillomavirus Recombinant Vaccine nonavalent 5 Trastuzumab 4 Tamoxifen 4 Standard of Care 4 Propofol 4 Paclitaxel 4 Immune Checkpoint Inhibitors 4 Esomeprazole 4 Enoxaparin 4 Doxorubicin 4 Bortezomib 4 Bismuth 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Granulocyte Colony-Stimulating Factor × 1 year × Clear all

NCT05753618 2026-02-09

REaCT-OGF

Ottawa Hospital Research Institute

Phase 4 Recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡